The global Cancer Biomarkers Market is estimated to be valued at US$ 21,643.9 million in 2023 and is expected to exhibit a CAGR of 14.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Cancer Biomarkers Market offers a wide range of products and services that aid in the diagnosis, prognosis, and treatment of various...
The Global PARP Inhibitor Biomarkers Market is estimated to be valued at US$ 907.1 million in 2023 and is expected to exhibit a CAGR of 24.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:The PARP Inhibitor Biomarkers market is experiencing significant growth due to the increasing incidence of cancer worldwide. PARP...